Narrative review / 2011
The usefulness of a neutropenic diet for cancer patients has never been scientifically proven.
This article reviews the evidence surrounding the use of the neutropenic diet in cancer patients undergoing chemotherapy. Although intended to protect against infection, recent studies have failed to show significant differences between placebo and intervention groups. Neutropenic patients face challenges including reduced quality of life, malnutrition, gastrointestinal side effects, food aversion, and vitamin-deficiency-related impaired immunity. Without scientific evidence supporting specific neutropenic diets, following standard government food safety guidelines is advised.
- Study type
- Narrative review
- Who was studied
- Cancer patients undergoing chemotherapy with neutropenia
- What was measured
- Efficacy of neutropenic diets in preventing infection and related challenges
THE PAPER
The benefit of the neutropenic diet: fact or fiction?
Jubelirer SJ. Oncologist, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.